Cargando…
An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083143/ https://www.ncbi.nlm.nih.gov/pubmed/24938355 http://dx.doi.org/10.1186/1477-7819-12-186 |
_version_ | 1782324336331325440 |
---|---|
author | Kataoka, Tatsuki R Yamashita, Nobuhiro Furuhata, Ayako Hirata, Masahiro Ishida, Takaki Nakamura, Ichiro Hirota, Seiichi Haga, Hironori Katsuyama, Eiji |
author_facet | Kataoka, Tatsuki R Yamashita, Nobuhiro Furuhata, Ayako Hirata, Masahiro Ishida, Takaki Nakamura, Ichiro Hirota, Seiichi Haga, Hironori Katsuyama, Eiji |
author_sort | Kataoka, Tatsuki R |
collection | PubMed |
description | Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) and negative for KIT, whereas most GISTs are ALK-negative and KIT-positive. Here, we describe a case of a spindle cell tumor in the wall of the urinary bladder. The spindle cells were positive for both ALK and KIT, and it was thus difficult to determine whether the tumor was an IMT or a GIST. We eventually diagnosed an IMT, because ALK gene rearrangement was confirmed by fluorescent in-situ hybridization. Cytoplasmic staining for KIT and the absence of other GIST markers, including DOG1 and platelet-derived growth factor α, indicated that the tumor was not a GIST. Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive. |
format | Online Article Text |
id | pubmed-4083143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40831432014-07-08 An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall Kataoka, Tatsuki R Yamashita, Nobuhiro Furuhata, Ayako Hirata, Masahiro Ishida, Takaki Nakamura, Ichiro Hirota, Seiichi Haga, Hironori Katsuyama, Eiji World J Surg Oncol Case Report Inflammatory myofibroblastic tumors (IMTs) and gastrointestinal stromal tumors (GISTs) are both spindle cell tumors, and occur rarely in the wall of the urinary bladder. In general, immunostaining allows differentiation of IMTs and GISTs. Most IMTs are positive for anaplastic lymphoma kinase (ALK) and negative for KIT, whereas most GISTs are ALK-negative and KIT-positive. Here, we describe a case of a spindle cell tumor in the wall of the urinary bladder. The spindle cells were positive for both ALK and KIT, and it was thus difficult to determine whether the tumor was an IMT or a GIST. We eventually diagnosed an IMT, because ALK gene rearrangement was confirmed by fluorescent in-situ hybridization. Cytoplasmic staining for KIT and the absence of other GIST markers, including DOG1 and platelet-derived growth factor α, indicated that the tumor was not a GIST. Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive. BioMed Central 2014-06-18 /pmc/articles/PMC4083143/ /pubmed/24938355 http://dx.doi.org/10.1186/1477-7819-12-186 Text en Copyright © 2014 Kataoka et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Case Report Kataoka, Tatsuki R Yamashita, Nobuhiro Furuhata, Ayako Hirata, Masahiro Ishida, Takaki Nakamura, Ichiro Hirota, Seiichi Haga, Hironori Katsuyama, Eiji An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall |
title | An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall |
title_full | An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall |
title_fullStr | An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall |
title_full_unstemmed | An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall |
title_short | An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall |
title_sort | inflammatory myofibroblastic tumor exhibiting immunoreactivity to kit: a case report focusing on a diagnostic pitfall |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083143/ https://www.ncbi.nlm.nih.gov/pubmed/24938355 http://dx.doi.org/10.1186/1477-7819-12-186 |
work_keys_str_mv | AT kataokatatsukir aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT yamashitanobuhiro aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT furuhataayako aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT hiratamasahiro aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT ishidatakaki aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT nakamuraichiro aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT hirotaseiichi aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT hagahironori aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT katsuyamaeiji aninflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT kataokatatsukir inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT yamashitanobuhiro inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT furuhataayako inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT hiratamasahiro inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT ishidatakaki inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT nakamuraichiro inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT hirotaseiichi inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT hagahironori inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall AT katsuyamaeiji inflammatorymyofibroblastictumorexhibitingimmunoreactivitytokitacasereportfocusingonadiagnosticpitfall |